Typhim Vi

BIOLOGICAL2 trials

Sponsors

Stanford University, Texas A&M University

Conditions

Healthy AdultsHepatitis AInflammatory ResponseInfluenzaTyphoid

Early Phase 1

Persistent Readiness Through Early Prediction Immunization Study

CompletedNCT05346302

Texas A&M UniversityInflammatory Response

Start: 2022-02-08End: 2022-12-21Updated: 2023-02-14

Phase 1

Effects of Aging on Primary and Secondary Vaccine Responses

CompletedNCT03312699

Stanford UniversityHealthy Adults, Hepatitis A, Influenza +1

Start: 2017-09-19End: 2023-12-31Updated: 2024-12-16

Related Papers

Volatile organic compound and proteomics data from the same exhaled breath condensate sample

Journal of Breath Research2025-07-231 citations

A randomized, triple-blinded, placebo-controlled clinical trial evaluating immune responses of Typhim Vi and PPSV23 vaccines in healthy adults: The PREP study

Vaccine2024-09-073 citations